๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The use of BRM-activated killer cells in adoptive immunotherapy: A pilot study with nine advanced cancer patients

โœ Scribed by Takusaburo Ebina; Yoshiaki Fujimiya; Tomohiro Yamaguchi; Naoko Ogama; Hiroko Sasaki; Noriko Isono; Youichi Suzuki; Ryuichi Katakura; Kazuya Tanaka; Kinya Nagata; Shoichi Takano; Keiji Tamura; Kazuko Uno; Tsunataro Kishida


Book ID
114420754
Publisher
Springer
Year
1998
Tongue
English
Weight
343 KB
Volume
11
Category
Article
ISSN
0921-299X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A phase II study of adoptive immunothera
โœ Daniel H. Palmer; Rachel S. Midgley; Noweeda Mirza; Elizabeth E. Torr; Forhad Ah ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 286 KB

This is a phase II clinical trial investigating the safety and efficacy of intravenous vaccination with mature autologous dendritic cells (DCs) pulsed ex vivo with a liver tumor cell line lysate (HepG2) in patients with advanced hepatocellular carcinoma (HCC). HCC is an attractive target for immunot